1. Home
  2. KLTO vs DFLI Comparison

KLTO vs DFLI Comparison

Compare KLTO & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • DFLI
  • Stock Information
  • Founded
  • KLTO 2019
  • DFLI 2020
  • Country
  • KLTO United States
  • DFLI United States
  • Employees
  • KLTO N/A
  • DFLI N/A
  • Industry
  • KLTO
  • DFLI Electronic Components
  • Sector
  • KLTO
  • DFLI Technology
  • Exchange
  • KLTO NYSE
  • DFLI Nasdaq
  • Market Cap
  • KLTO 5.0M
  • DFLI 5.0M
  • IPO Year
  • KLTO N/A
  • DFLI N/A
  • Fundamental
  • Price
  • KLTO $0.16
  • DFLI $0.50
  • Analyst Decision
  • KLTO
  • DFLI Strong Buy
  • Analyst Count
  • KLTO 0
  • DFLI 4
  • Target Price
  • KLTO N/A
  • DFLI $12.83
  • AVG Volume (30 Days)
  • KLTO 152.3K
  • DFLI 252.3K
  • Earning Date
  • KLTO 05-15-2025
  • DFLI 05-13-2025
  • Dividend Yield
  • KLTO N/A
  • DFLI N/A
  • EPS Growth
  • KLTO N/A
  • DFLI N/A
  • EPS
  • KLTO N/A
  • DFLI N/A
  • Revenue
  • KLTO N/A
  • DFLI $50,645,000.00
  • Revenue This Year
  • KLTO N/A
  • DFLI $42.48
  • Revenue Next Year
  • KLTO N/A
  • DFLI $42.95
  • P/E Ratio
  • KLTO N/A
  • DFLI N/A
  • Revenue Growth
  • KLTO N/A
  • DFLI N/A
  • 52 Week Low
  • KLTO $0.11
  • DFLI $0.56
  • 52 Week High
  • KLTO $13.10
  • DFLI $13.14
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • DFLI 18.84
  • Support Level
  • KLTO N/A
  • DFLI $0.60
  • Resistance Level
  • KLTO N/A
  • DFLI $0.67
  • Average True Range (ATR)
  • KLTO 0.00
  • DFLI 0.09
  • MACD
  • KLTO 0.00
  • DFLI 0.02
  • Stochastic Oscillator
  • KLTO 0.00
  • DFLI 7.39

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a highly cost-effective storage solution.

Share on Social Networks: